Type-specific prevalence of genital human papillomaviruses in benign, premalignant, and malignant biopsies in patients from Greece

Sexually Transmitted Diseases

Volumn 24, Issue 8, 1997, Pages 469-474

  Labropoulou, Vassiliki ^c   Diakomanolis, Emmanouel ^c   Dailianas, Stefanos ^c   Kalpaktsoglou, Konstantinos ^c   Balamotis, Alexandros ^a   Mavromara, Penelope ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER GRADING; FEMALE; GREECE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; SOUTHERN BLOTTING; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

CARCINOMA; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GREECE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 0030760623     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199709000-00005     Document Type: Article

References (38)

1. Zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989; 49:4677-4680.
2. De Villiers EM. Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol 1994; 186:1-11.
3. De Villiers EM. Heterogeneity in the human papillomavirus group. J Virol 1989; 63:4898-4903.
4. Galloway D. Navigating the descent into papillomavirus hell. J Infect Dis 1994; 170:1075-1076.
5. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87:796-802.
6. Bergeron C, Barrasso R, Beaudenon S, Flamant P, Croissant O, Orth G. Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions. Am J Surg Pathol 1992; 16:641-649.
7. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancanster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk association of 15 common anogenital types. Obstet Gynecol 1992; 79:328-337.
8. Lungu O, Sun XW, Felix J, Richart RM, Silverstein S, Wright TC. Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA 1992; 267:2493-2496.
9. Matsukura T, Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions. Int J Cancer 1995; 61:13-22.
10. Olsen AO, Gjoen K, Sauer T, et al. Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case-control study. Int J Cancer 1995; 61:312-315.
11. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327:1272-1278.
12. Shah KV. Human papillomavirus and other biological markers in cervical cancer. In: Munoz N, Bosch FX, Shah KV, et al, eds. The Epidemiology of Human Papillomavirus and Cervical Cancer. Lyon Cedex, France: IARC Scientific Publications, 1992:209-218.
13. Kurman RJ, Schiffman MH, Lancaster WD, et al. Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for HPV 18 in rapid progression. Am J Obstet Gynecol 1988; 159:293-296.
14. Hecht JL, Kadish AS, Jiang G, Burk RD. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int J Cancer 1995; 60:369-376.
15. McLachlin CM, Tate JE, Zitz JC, Sheets EE, Crum CP. Human papillomavirus type 18 and intraepithelial lesions of the cervix. Am J Pathol 1994; 144:141-147.
16. Cuzick J, Szarewski A, Terry G, et al. Human papillomavirus testing in primary cervical screening. Lancet 1995; 345:1533-1536.
17. Wu CH, Lee MF, Chang MC, Ho SC. Detection of human papillomavirus types in cervical lesions of patients from Taiwan by polymerase chain reaction. Sex Transm Dis 1994; 6:309-314.
18. Ikenberg H, Maass N, Runge M. HPV 18 in cervical specimens from the Cook Islands. Int J Cancer 1994; 57:137.
19. Labropoulou V, Balamotis A, Tosca A, Rotola A, MavromaraNazos P. Typing of human papillomaviruses in condylomata acuminata from Greece. J Med Virol 1994; 42:259-263.
20. Labropoulou V, Diakomanolis E, Dailianas S, et al. Genital papillomavirus in Greek women with high-grade cervical intraepithelial neoplasia and cervical carcinoma. J Med Virol 1996; 48:80-87.
21. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994; 169:235-240.
22. Ho GYF, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87:1365-1370.
23. Chua KL, Hjerpe A. Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma. Cancer 1996; 77:121-127.
24. Kataja V, Syrjanen S, Mantyjars R, Yliskoski M, Saarikoskis S, Syrjanen K. Prognostic factors for cervical human papillomavirus infections. Sex Trasm Dis 1992; 19:154-160.
25. Remmink AJ, Walboomers JMM, Helmerhorst TJM, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995; 61:306-311.
26. Tabarra S, Saleh AM, Barber S, Anderson W, Taylor PT, Crum CP. The Bethesda classification for squamous intraepithelial lesions: histologic, cytologic and viral correlates. Obstet Gynecol 1992; 72:338-346.
27. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection infection in female university students as determined by PCR-based method. JAMA 1991;265: 472-477.
28. Ting Y, Manos MM. Detection and typing of genital human papillomaviruses. In: Innis MA, Gelfand DH, Sninsky JJ, et al, eds. PCR Protocol: A Guide to Methods and Applications. San Diego: Academic Press, 1990:356-367.
29. Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Orth G. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 1990; 335:1171-1174.
30. Lungu O, Wright J, Silverstein S. Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes 1992; 6:145-152.
31. Bernand HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomavirus by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170:1077-1085.
32. Zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991; 184:9-13.
33. Berkley AS, LiVolsi VA, Schwartz PE. Advanced squamous cell carcinoma of the cervix with recent normal Papanicolaou tests. Lancet 1980; 2:375.
34. Von Knebel Doeberitz M. Papillomaviruses in human disease: part II. Molecular biology and immunology of papillomavirus infections and carcinogenesis. Eur J Med 1992; 1:485-491.
35. Chabaud M, Le Cann P, Mayelo V, et al. Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women. J Med Virol 1996; 49:259-263.
36. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994; 6:157-162.
37. Ong CK, Chan SY, Campo MS, et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 1993; 67:6424-6431.
38. Katase K, Teshima H, Hirai Y, Hasumi K. Natural history of cervical human papillomavirus lesions. Intervirology 1995; 38:192-194.